Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer

被引：112

作者：

de Streel, Gregoire ^{[1
]}

Bertrand, Charlotte ^{[1
]}

Chalon, Nicolas ^{[1
]}

Lienart, Stephanie ^{[1
]}

Bricard, Orian ^{[1
]}

Lecomte, Sara ^{[1
]}

Devreux, Julien ^{[1
]}

Gaignage, Melanie ^{[1
]}

De Boeck, Gitte ^{[2
]}

Marien, Lore ^{[2
]}

Van de Walle, Inge ^{[2
]}

van der Woning, Bas ^{[2
]}

Saunders, Michael ^{[2
]}

de Haard, Hans ^{[2
]}

Vermeersch, Elien ^{[3
]}

Maes, Wim ^{[3
]}

Deckmyn, Hans ^{[3
]}

Coulie, Pierre G. ^{[1
]}

van Baren, Nicolas ^{[1
]}

Lucas, Sophie ^{[1
]}

机构：

[1] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium

[2] Argenx, B-9052 Zwijnaarde, Belgium

[3] Katholieke Univ Leuven, IRF Life Sci, Lab Thrombosis Res, Campus Kulak Kortrijk, B-8500 Kortrijk, Belgium

来源：

NATURE COMMUNICATIONS | 2020年 / 11卷 / 01期

基金：

欧洲研究理事会;

关键词：

REGULATORY T-CELLS; LATENT TGF-BETA; ANTITUMOR-ACTIVITY; PD-1; BLOCKADE; ANTIBODIES; GENE; RECEPTOR;

D O I：

10.1038/s41467-020-17811-3

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

TGF-beta 1, beta 2 and beta 3 bind a common receptor to exert vastly diverse effects in cancer, supporting either tumor progression by favoring metastases and inhibiting anti-tumor immunity, or tumor suppression by inhibiting malignant cell proliferation. Global TGF-beta inhibition thus bears the risk of undesired tumor-promoting effects. We show that selective blockade of TGF-beta 1 production by Tregs with antibodies against GARP:TGF-beta 1 complexes induces regressions of mouse tumors otherwise resistant to anti-PD-1 immunotherapy. Effects of combined GARP:TGF-beta 1/PD-1 blockade are immune-mediated, do not require Fc gamma R-dependent functions and increase effector functions of anti-tumor CD8(+) T cells without augmenting immune cell infiltration or depleting Tregs within tumors. We find GARP-expressing Tregs and evidence that they produce TGF-beta 1 in one third of human melanoma metastases. Our results suggest that anti-GARP:TGF-beta 1 mAbs, by selectively blocking a single TGF-beta isoform emanating from a restricted cellular source exerting tumor-promoting activity, may overcome resistance to PD-1/PD-L1 blockade in patients with cancer.

引用

页数：15

共 46 条

[31] Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression [J].

Shevach, Ethan M. .

IMMUNITY, 2009, 30 (05) :636-645

[32] Latent TGF-β structure and activation [J].

Shi, Minlong ;

Zhu, Jianghai ;

Wang, Rui ;

Chen, Xing ;

Mi, Lizhi ;

Walz, Thomas ;

Springer, Timothy A. .

NATURE, 2011, 474 (7351) :343-U370

[33]

Shichijo S, 1996, INT J CANCER, V65, P709

[34] Blocking immunosuppression by human Tregs in vivo with antibodies targeting integrin αVβ8 [J].

Stockis, Julie ;

Lienart, Stephanie ;

Colau, Didier ;

Collignon, Amandine ;

Nishimura, Stephen L. ;

Sheppard, Dean ;

Coulie, Pierre G. ;

Lucas, Sophie .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (47) :E10161-E10168

[35] Role of GARP in the activation of latent TGF-β1 [J].

Stockis, Julie ;

Dedobbeleer, Olivier ;

Lucas, Sophie .

MOLECULAR BIOSYSTEMS, 2017, 13 (10) :1925-1935

[36] Membrane protein GARP is a receptor for latent TGF-β on the surface of activated human Treg [J].

Stockis, Julie ;

Colau, Didier ;

Coulie, Pierre G. ;

Lucas, Sophie .

EUROPEAN JOURNAL OF IMMUNOLOGY, 2009, 39 (12) :3315-3322

[37] Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles [J].

Subramanian, A ;

Tamayo, P ;

Mootha, VK ;

Mukherjee, S ;

Ebert, BL ;

Gillette, MA ;

Paulovich, A ;

Pomeroy, SL ;

Golub, TR ;

Lander, ES ;

Mesirov, JP .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (43) :15545-15550

[38] Reporting of preclinical tumor-graft cancer therapeutic studies [J].

Sugar, Elizabeth ;

Pascoe, Adam J. ;

Azad, Nilofer .

CANCER BIOLOGY & THERAPY, 2012, 13 (13) :1262-1268

[39] TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance [J].

Thomas, DA ;

Massagué, J .

CANCER CELL, 2005, 8 (05) :369-380

[40] Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies [J].

Vargas, Frederick Arce ;

Furness, Andrew J. S. ;

Litchfield, Kevin ;

Joshi, Kroopa ;

Rosenthal, Rachel ;

Ghorani, Ehsan ;

Solomon, Isabelle ;

Lesko, Marta H. ;

Ruef, Nora ;

Roddie, Claire ;

Henry, Jake Y. ;

Spain, Lavinia ;

Ben Aissa, Assma ;

Georgiou, Andrew ;

Wong, Yien Ning Sophia ;

Smith, Myles ;

Strauss, Dirk ;

Hayes, Andrew ;

Nicol, David ;

O'Brien, Tim ;

Martensson, Linda ;

Ljungars, Anne ;

Teige, Ingrid ;

Frendeus, Bjorn ;

Pule, Martin ;

Marafioti, Teresa ;

Gore, Martin ;

Larkin, James ;

Turajlic, Samra ;

Swanton, Charles ;

Peggs, Karl S. ;

Quezada, Sergio A. .

CANCER CELL, 2018, 33 (04) :649-+

← 1 2 3 4 5 →